ALPHA-2-ADRENERGIC SENSITIVITY IN PARKINSONS-DISEASE

被引：20

作者：

BERLAN, M

RASCOL, O

BELIN, J

MOATTI, JP

RASCOL, A

MONTASTRUC, JL

机构：

[1] CHU TOULOUSE,FAC MED,INSERM,U317,PHARMACOL MED & CLIN LAB,37 ALLEES J GUESDE,F-31073 TOULOUSE,FRANCE

[2] CHU PURPAN,SERV NEUROL,TOULOUSE,FRANCE

[3] HOP LA GRAVE,BIOCHIM MED LAB,F-31052 TOULOUSE,FRANCE

来源：

CLINICAL NEUROPHARMACOLOGY | 1989年 / 12卷 / 02期

关键词：

D O I：

10.1097/00002826-198904000-00010

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：138 / 144

页数：7

共 14 条

[1] EVIDENCE THAT EPINEPHRINE ACTS PREFERENTIALLY AS AN ANTILIPOLYTIC AGENT IN ABDOMINAL HUMAN SUBCUTANEOUS FAT-CELLS - ASSESSMENT BY ANALYSIS OF BETA AND ALPHA2 ADRENOCEPTORS PROPERTIES [J].

BERLAN, M ;

LAFONTAN, M .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1985, 15 (06) :341-348

[2]

BROWN MJ, 1985, ADRENERGIC RECEPTORS, V1, P629

[3]

DOLE VP, 1960, J BIOL CHEM, V235, P2295

[4]

GOLDBERG MR, 1983, PHARMACOL REV, V35, P143

[5] THE HEPATIC ALPHA1-ADRENERGIC RECEPTOR [J].

GOODHARDT, M ;

FERRY, N ;

AGGERBECK, M ;

HANOUNE, J .

BIOCHEMICAL PHARMACOLOGY, 1984, 33 (06) :863-868

[6] PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].

HOEHN, MM ;

YAHR, MD .

NEUROLOGY, 1967, 17 (05) :427-&

[7]

HONYKIEWICZ O, 1986, ADV NEUROL, V45, P19

[8]

HSU WH, 1986, J ENDOCRINOL INVEST, V9, P349, DOI 10.1007/BF03346940

[9]

MARKIANOS M, 1982, ACTA NEUROL SCAND, V66, P267, DOI 10.1111/j.1600-0404.1982.tb04524.x

[10] HETEROGENEOUS DISTRIBUTION OF BETA-ADRENOCEPTOR AND ALPHA-2-ADRENOCEPTOR BINDING-SITES IN HUMAN FAT-CELLS FROM VARIOUS FAT DEPOSITS - FUNCTIONAL CONSEQUENCES [J].

MAURIEGE, P ;

GALITZKY, J ;

BERLAN, M ;

LAFONTAN, M .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1987, 17 (02) :156-165

← 1 2 →